Literature DB >> 18937628

The genetic contribution to systemic lupus erythematosus.

Lindsey A Criswell1.   

Abstract

We are currently witnessing an explosion of information about the genetic contribution to complex human diseases such as systemic lupus erythematosus (SLE). These genetic discoveries have profound implications for efforts to more fully characterize etiologic pathways and mechanisms. Further, these etiologic insights should lead to improved diagnostic and prognostic tools and inform the development of more specific therapies for SLE and related conditions. The article summarizes the evidence supporting a role for genetic factors in SLE, highlights the clinical and genetic complexity of the disease, reviews the genes that have established contributions to the risk of SLE and specific disease manifestations, and discusses the recent data emerging from genomewide association studies of SLE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18937628

Source DB:  PubMed          Journal:  Bull NYU Hosp Jt Dis        ISSN: 1936-9719


  17 in total

1.  Evidence for both copy number and allelic (NA1/NA2) risk at the FCGR3B locus in systemic lupus erythematosus.

Authors:  David L Morris; Amy L Roberts; Abigail S Witherden; Ruth Tarzi; Paula Barros; John C Whittaker; Terence H Cook; Timothy J Aitman; Timothy J Vyse
Journal:  Eur J Hum Genet       Date:  2010-05-05       Impact factor: 4.246

Review 2.  Cytokines: Names and Numbers You Should Care About.

Authors:  Stephen R Holdsworth; Poh-Yi Gan
Journal:  Clin J Am Soc Nephrol       Date:  2015-05-04       Impact factor: 8.237

3.  From the Large Scale Expression Analysis of Lupus Nephritis to Targeted Molecular Medicine.

Authors:  Celine C Berthier; Matthias Kretzler; Anne Davidson
Journal:  J Data Mining Genomics Proteomics       Date:  2012-03-27

4.  Plasminogen activator inhibitor-1 polymorphisms (-844 G>A and HindIII C>G) in systemic lupus erythematosus: association with clinical variables.

Authors:  Jorge Ramón Padilla-Gutiérrez; Claudia Azucena Palafox-Sánchez; Yeminia Valle; Gerardo Orozco-Barocio; Edith Oregón-Romero; Mónica Vázquez-Del Mercado; Héctor Rangel-Villalobos; Mara Anaís Llamas-Covarrubias; José Francisco Muñoz-Valle
Journal:  Clin Exp Med       Date:  2010-06-22       Impact factor: 3.984

5.  MHC region and risk of systemic lupus erythematosus in African American women.

Authors:  Edward A Ruiz-Narvaez; Patricia A Fraser; Julie R Palmer; L Adrienne Cupples; David Reich; Ying A Wang; John D Rioux; Lynn Rosenberg
Journal:  Hum Genet       Date:  2011-06-22       Impact factor: 4.132

6.  A single-nucleotide polymorphism of the TNFSF4 gene is associated with systemic lupus erythematosus in Chinese Han population.

Authors:  Sheng-Quan Zhang; Jian-Wen Han; Liang-Dan Sun; Wen-Sheng Lu; Xian-Yong Yin; Xue-Jun Zhang; Sen Yang
Journal:  Rheumatol Int       Date:  2009-12-13       Impact factor: 2.631

7.  Identification of MAMDC1 as a candidate susceptibility gene for systemic lupus erythematosus (SLE).

Authors:  Anna Hellquist; Marco Zucchelli; Cecilia M Lindgren; Ulpu Saarialho-Kere; Tiina M Järvinen; Sari Koskenmies; Heikki Julkunen; Päivi Onkamo; Tiina Skoog; Jaana Panelius; Anne Räisänen-Sokolowski; Taina Hasan; Elisabeth Widen; Iva Gunnarson; Elisabet Svenungsson; Leonid Padyukov; Ghazaleh Assadi; Linda Berglind; Ville-Veikko Mäkelä; Katja Kivinen; Andrew Wong; Deborah S Cunningham Graham; Timothy J Vyse; Mauro D'Amato; Juha Kere
Journal:  PLoS One       Date:  2009-12-07       Impact factor: 3.240

Review 8.  Use of type I interferon-inducible mRNAs as pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFNα antibody, in systemic lupus erythematosus.

Authors:  Yihong Yao; Brandon W Higgs; Laura Richman; Barbara White; Bahija Jallal
Journal:  Arthritis Res Ther       Date:  2010-04-14       Impact factor: 5.156

9.  Genetic polymorphisms of CYP2D6 oxidation in patients with systemic lupus erythematosus.

Authors:  Jadwiga Skrętkowicz; Małgorzata Barańska; Anna Kaczorowska; Mariola Rychlik-Sych
Journal:  Arch Med Sci       Date:  2011-11-08       Impact factor: 3.318

10.  Sifalimumab, a human anti-interferon-α monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study.

Authors:  Michelle Petri; Daniel J Wallace; Alberto Spindler; Vishala Chindalore; Kenneth Kalunian; Eduardo Mysler; C Michael Neuwelt; Gabriel Robbie; Wendy I White; Brandon W Higgs; Yihong Yao; Liangwei Wang; Dominique Ethgen; Warren Greth
Journal:  Arthritis Rheum       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.